The Orange Pill Podcast

Anxiety is often framed as a psychological condition- but what if part of the story is biological? Emerging research in nutritional psychiatry is uncovering a consistent metabolic signature in individuals with anxiety: reduced levels of choline in the brain. In this episode, we explore the science behind this discovery, including: ✔ An 8% reduction in brain choline linked to anxiety ✔ The role of...

For decades, cardiovascular care has focused on slowing disease and not reversing it. But new clinical data is challenging that paradigm. In this episode, we break down emerging evidence showing that high-dose Nattokinase, a fibrinolytic enzyme derived from fermented soy, may do more than support heart health. It may actively reduce arterial plaque. From a 36% reduction in carotid plaque size to i...

100 episodes in and we’re tackling one of the most critical shifts in the industry. In Episode 100 of the Orange Pill Podcast, we break down recent FDA enforcement actions from CDER’s BIMO program that reveal a hard truth: Your supplement can become a drug- based on how you study it. From enrolling diseased populations without an IND to unethical consent practices and compromised data integrity, t...

What if the safety data behind a drug… couldn’t be verified? In Episode 99 of the Orange Pill Podcast, we break down a recent FDA Warning Letter that exposed a troubling “liaison” model, where a contract research company claimed ownership of studies it never actually conducted. From falsified study directors to missing raw data, this case reveals how gaps in oversight can compromise the very found...

You trust that every ingredient in your food has been reviewed for safety. But what if no one is actually checking? In Episode 98 of the Orange Pill Podcast, we unpack the GRAS loophole- a decades-old regulatory pathway that allows companies to self-affirm the safety of food ingredients, often without notifying the FDA. From legacy additives like BHA to the growing concern around endocrine-disrupt...

By 2050, the world will need to feed 10 billion people. Traditional food innovation simply isn’t fast enough. In Episode 97 of the Orange Pill Podcast, we explore how Artificial Intelligence is transforming the way food is discovered, designed, and delivered- from identifying hidden health compounds in plants to predicting taste, texture, and nutrition before a product even reaches the lab. From p...

For years, multivitamins have lived in a scientific gray zone- praised by some, dismissed by others. Now one of the largest supplement trials ever conducted may finally shift the conversation. In Episode 96 of the Orange Pill Podcast, we break down the results of the 21,000+ participant COSMOS trial, revealing how daily multivitamins may slow biological aging and how cocoa flavanols could reduce c...

Your supplements may no longer come from farms-  they might come from labs. In Episode 95 of the Orange Pill Podcast, we break down the FDA’s upcoming town hall examining whether ingredients produced through precision fermentation, cell culture, and recombinant biotechnology still qualify as “dietary ingredients” under the 1994 DSHEA law. At the center of the debate: Section 201(ff)(1)(E),  a sing...

What if your supplement is legal in one state… but restricted the moment you cross a bridge? In Episode 94, we break down the 2026 legislative shift reshaping the supplement industry - from New York’s age restrictions to the federal Uniformity Act and the looming hemp “THC cliff” in the Farm Bill. The era of 50 different rulebooks may be ending. Or it may just be getting started.

2026 isn’t business as usual. It’s a legislative wildfire. From dye bans and heavy metal mandates to accidental labeling laws and GRAS reform, state legislatures are rewriting food and supplement policy at breakneck speed. In Episode 93 of the Orange Pill Podcast, we break down the surge of state-level bills that could fracture the national market,  and why manufacturers may soon face 50 different...

80% of seafood. Over half of fresh fruit. Thousands of supplements. That’s how much of the American diet is produced overseas. So what happens when FDA foreign inspections hit historic lows? In Episode 92 of the Orange Pill Podcast, we unpack the sharp decline in international food and supplement facility inspections, the administrative breakdown behind it, and what it means for public health, reg...

For over 2,000 years, turmeric has been revered as a healing powerhouse, from ancient Ayurveda to today’s booming $155M+ curcumin supplement market. With more than 11,000 scientific publications supporting its anti-inflammatory and antioxidant benefits, it’s long been considered one of the safest “superfoods” on the planet. So why are global regulators suddenly issuing liver safety warnings? In Ep...

Ultra-processed foods now make up over half of the average adult’s calories and nearly 60% of children’s diets. They look harmless. They’re marketed as “natural.” Some even carry health halos. But behind the packaging lies a system built on loopholes, engineered starches, and thousands of additives the FDA may never have formally reviewed. In Episode 90 of the Orange Pill Podcast, we unpack the gr...

High heat built the modern food system. But it may also be limiting it. In Episode 89, we explore how Novel Food Processing (NFP) technologies are transforming protein at the molecular level, unlocking better texture, higher bioavailability, improved digestibility, and cleaner labels without sacrificing safety. From electricity-powered milk processing to ultra-high pressure seafood engineering, th...

What if many of the ingredients in your food were never reviewed by the FDA? In Episode 88 of the Orange Pill Podcast, we break down the newly introduced GRAS Oversight and Transparency Act (February 3, 2026); a bill that aims to close one of the most controversial loopholes in U.S. food regulation. For decades, the “Generally Recognized as Safe” (GRAS) framework has allowed companies to self-dete...

Erythritol has earned a near-perfect reputation in the clean-eating world. It’s natural, calorie-free, keto-friendly, and widely considered one of the safest sugar substitutes on the market. But new research from the University of Colorado suggests that this confidence may be dangerously misplaced. In Episode 87 of the Orange Pill Podcast, we unpack a startling new study from the DeSouza laborator...

Many wellness and nutraceutical companies believe that calling a product a dietary supplement creates a regulatory safe zone. FDA enforcement actions tell a very different story. In Episode 86 of the Orange Pill Podcast, we break down the FDA’s Bioresearch Monitoring (BIMO) Program and analyze recent FDA Warning Letters that caught sponsors, CROs, and IRBs completely off guard. This episode explai...

For years, protein dominated the wellness conversation. Shakes, bars, and macro tracking became the gold standard of “healthy.” But a new movement is rapidly reshaping nutrition culture  and it isn’t coming from gyms or supplement brands. It’s coming from the gut. In Episode 85 of the Orange Pill Podcast, we unpack the science behind #Fibermaxxing - the viral trend shifting attention from protein...

For decades, America’s food system operated in a gray zone where chemicals could quietly enter the supply chain, nutrition guidance lagged behind chronic disease, and safety was often reactive rather than preventive. That era is ending. In Episode 84 of the Orange Pill Podcast, we unpack the FDA’s newly solidified Human Foods Program (HFP) and its sweeping 2026 agenda, a regulatory blueprint that...

For nearly a century, U.S. cosmetic regulation remained largely unchanged. That era officially ended with the passage of the Modernization of Cosmetics Regulation Act (MoCRA), and now, the FDA is racing to catch up. In Episode 83 of the Orange Pill Podcast, we unpack five major regulatory developments that signal a fundamental shift in how cosmetics are tested, labeled, and enforced in the United...

The world is facing a neurological emergency. Dementia cases are projected to nearly triple by 2050, and despite decades of pharmaceutical research, effective, scalable solutions remain limited. This has pushed scientists to look beyond single-target drugs and toward food-based, systems-level interventions. In Episode 82 of the Orange Pill Podcast, we explore why red beetroot is emerging as a seri...

Colostrum, often called “liquid gold”, has taken over longevity circles, biohacking podcasts, and premium supplement shelves. Marketed for everything from gut health to immune resilience and anti-aging, its popularity has surged faster than human clinical research. In Episode 81 of the Orange Pill Podcast, we break down a newly published randomized, double-blind, placebo-controlled clinical trial...

Neuropathic pain affects up to 18% of the global population and remains one of the most difficult chronic conditions to manage. Existing therapies often come with serious trade-offs such as sedation, dependency, and limited long-term relief, highlighting the urgent need for safer, more effective solutions. In Episode 80 of the Orange Pill Podcast, we explore fascinating new preclinical research on...

When you scan a food or supplement label, you might assume you’re seeing the most credible health information available. But what if some of the most authoritative, government-backed science is being kept off labels altogether? In this episode of the Orange Pill Podcast, we unpack a new legal battle that’s putting the FDA’s regulatory authority, free speech, and consumer rights under the spotlight...

More than one in four adults struggle to fall or stay asleep and while prescription sleep aids can help, they often come with side effects like grogginess, confusion, and memory impairment. That’s why researchers are increasingly searching for safer, evidence-based alternatives. In this episode of the Orange Pill Podcast, we dive into a fascinating new triple-blind, placebo-controlled clinical tri...